Last deal

$35M

Amount

Series B

Stage

06.06.2018

Date

5

all rounds

$147.6M

Total amount

General

About Company
Hangzhou Just Biotherapeutics is a high-tech design company that accelerates the development of bio-medicine.

Industry

Sector :

Subsector :

Keywords :

Also Known As

奕安济世, Yian Jishi

founded date

01.01.2015

Operating Status

Closed

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company offers technology that uses protein, process, and manufacturing sciences to develop biologics while reducing manufacturing costs. They provide CDMO services for large molecules and have sites in China and the US. Their Hangzhou Manufacturing GMP Facility uses advanced biological process technology and flexible modular facilities to improve product control and decrease costs. They offer comprehensive services to meet clients' needs for clinical trials and IND filing in both China and the US.